Evidence map›Paper›PMID 19483727›Full record

ArticleOncogene2009

Degradation of cyclin A is regulated by acetylation.

F Mateo, M Vidal-Laliena, N Canela, L Busino, M A Martinez-Balbas, M Pagano, N Agell, O Bachs

Abstract read
In one paragraph

Article in Oncogene, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.

0numbers the graph read from it
0cells of the map it votes in
29citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

29 citing papers in PubMed, 59 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Role of p27Oncotarget · 2018
    Review
  10. Article
  11. Article
  12. Article
  13. Acetylation mediates Cx43 reduction caused by electrical stimulation.Journal of molecular and cellular cardiology · 2015
    Article
  14. Histone deacetylase 3 regulates cyclin A stability.The Journal of biological chemistry · 2013
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

F MateoFaculty of Medicine, Department of Cell Biology and Pathology, University of Barcelona, Barcelona, Spain.
M Vidal-Laliena
N Canela
L Busino
M A Martinez-Balbas
M Pagano
N Agell
O Bachs
Universitat de Barcelona · ESNew York University · USConsejo Superior de Investigaciones Científicas · ES

Funding

REGULATION OF THE GI PHASE BY THE UBIQUITIN PATHWAYR01GM057587 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI PAGANO, MICHELE · 1998 to 2018
$7.8M
F-box proteins: deregulated cell cycle control and proteolysis in cancerR37CA076584 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI PAGANO, MICHELE · 2006 to 2016
$4.7M
Role of the SCF/Fbxo15 ubiquitin ligase in stem cells and cancer biologyR21CA161108 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI PAGANO, MICHELE · 2011 to 2012
$404k
Novel Substrates of SCF Ubiquitin Ligases in Cell Cycle Control and CancerR21CA125173 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI PAGANO, MICHELE · 2007 to 2008
$372k
Howard Hughes Medical InstituteNCI NIH HHS R21 CA125173NCI NIH HHS R21-CA125173NCI NIH HHS R21 CA161108NCI NIH HHS R37 CA076584NCI NIH HHS R37-CA76584NIGMS NIH HHS R01 GM057587NIGMS NIH HHS R01-GM57587
6 · The paper itself

Abstract

Cyclin A accumulates at the onset of S phase, remains high during G(2) and early mitosis and is degraded at prometaphase. Here, we report that the acetyltransferase P/CAF directly interacts with cyclin A that as a consequence becomes acetylated at lysines 54, 68, 95 and 112. Maximal acetylation occurs simultaneously to ubiquitylation at mitosis, indicating importance of acetylation on cyclin A stability. This was further confirmed by the observation that the pseudoacetylated cyclin A mutant can be ubiquitylated whereas the nonacetylatable mutant cannot. The nonacetylatable mutant is more stable than cyclin A WT (cycA WT) and arrests cell cycle at mitosis. Moreover, in cells treated with histone deacetylase inhibitors cyclin A acetylation increases and its stability decreases, thus supporting the function of acetylation on cyclin A degradation. Although the nonacetylatable mutant cannot be ubiquitylated, it interacts with the proteins needed for its degradation (cdks, Cks, Cdc20, Cdh1 and APC/C). In fact, its association with cdks is increased and its complexes with these kinases display higher activity than control cycA WT-cdk complexes. All these results indicate that cyclin A acetylation at specific lysines is crucial for cyclin A stability and also has a function in the regulation of cycA-cdk activity.

Indexed as

AcetylationAnimalsChlorocebus aethiopsCOS CellsCyclin ACyclin-Dependent Kinase 2HeLa CellsHumansLysineMutationp300-CBP-Associated Factorp300-CBP Transcription FactorsCyclin ACyclin-Dependent Kinase 2Lysinep300-CBP-Associated Factorp300-CBP Transcription Factors

Identifiers

PMID19483727
PMCPMC3869789
OpenAlexW1967425351

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.